You just read:

Parker Institute for Cancer Immunotherapy Scientists to Present Research at ASCO 2017 on IDO Pathway Inhibitors, Novel CAR-Ts and the Microbiome's Potential in Immunotherapy

News provided by

Parker Institute for Cancer Immunotherapy

Jun 01, 2017, 09:01 ET